Home Skin Research Research Overview Products NBI Core Science Clinical Questionnaire
 
CORE SCIENCE
 
 
 


Nerium SkinCare, Inc.® has developed the "first of its kind" topical natural skin care cosmetic products based on an entirely new extraction process NBio-PL² ™ resulting in a new ingredient providing the best of the Nerium oleander plant and Aloe Vera properties. We want to share what we've learned through our development and testing of these new skin care products. Research to date has shown these natural products are safe and, in terms of effectiveness, consumers have confirmed the products works better for them than what they have found previously in the marketplace.

Nerium SkinCare's products are founded on the commitment to further develop this new ingredient technology, the core science, and provides for the continuing research of the Nerium oleander plant and other natural ingredients. This research and new ingredient technology has provided Nerium SkinCare with the opportunity and ability to formulate and develop for the consumer a unique, innovative, quality based  ever expanding pipeline of natural skin care products. Initial product development has focused on cosmetic applications of NAE-8® for topical use. (See NeriumAD® topical age-defying cosmetic products.)

The development of this new ingredient breakthrough extraction-reaction technology has provided for a new patented process NBio-PL² to extract from a botanical biomass and the creation of new active ingredients in a way that preserves their unique and beneficial properties. Specifically, this ingredient development process incorporates pure liquid Aloe Vera to extract-react with the unique Nerium oleander plant components in a way that creates the unique ingredient possessing the beneficial properties of both plants (this process is without any additional solvents). This has allowed Nerium SkinCare to create, formulate and develop the "first of its kind" skin care products for topical applications utilizing NAE-8® (Nerium Aloe Extract).


Historical Use - Nerium oleander and Aloe Vera plants

Historical use of the Nerium oleander plant has been reported in ancient texts and folklore for more than 1500 years. The Nerium oleander plant has been used traditionally as folk remedies for a wide variety of conditions. Within the past decade there has been a substantial increase in the number of studies reported in peer-reviewed science journals that deal with Nerium oleander and its properties.


The Aloe Vera plant has also been well known for centuries for its properties; the raw plant and commercial preparations can be used. There are a vast array of products on the market containing Aloe Vera used in topical dressings, drinks, and skin care applications. .

Today Nerium SkinCare has learned how to create a new ingredient through a patented process that is able to combine some of the unique properties/molecules of both plants.


Product Formulation and Mfg.

Nerium SkinCare is dedicated to offering solutions that are based on proven science and actual customer use experience. Products offered to the consumer will continue to be founded on continuing research at leading medical institutions using the latest scientific methods and technology. Products are nature based and scientifically developed and Nerium SkinCare oversees the quality control process from seed to finished product.

Nerium SkinCare's product formulation and production starts with the science developed from the USA-based environmentally responsible and earth-friendly farming operations, where fields of naturally grown Nerium oleander plants provide the raw material for Nerium SkinCare's botanical NAE-8® ingredient. Nerium SkinCare has over a decade of experience commercially growing the Nerium oleander plant to provide a renewable and dedicated source of biomass. Farming operations are considered all natural to meet the biomass standards required for biotechnology research and product formulation (without pesticides, etc.).

Product formulation has focused on the key NAE-8 ® ingredient and can be enhanced with fragrance, coloration, strength/potency, absorption/anti-absorption components, moisturizing components and any additional ingredients for target applications/markets.  GMP manufacturing facilities provide for product production.  Dr. Robert Newman's initial characterization and pharmacology research of the major biochemical and biological properties of Nerium oleander has served as the basis for quality control for the production of the Nerium Ingredients and associated products. Production yield, product stability testing, standardization, and clinical safety trials are ongoing, providing additional data for future regulatory requirements. The experience and ability to formulate and add additional ingredients to the multiple products required for Nerium SkinCare's success is in place.


 

Initial Safety and Clinical Testing

Testing for product safety and clinical application was initiated with Science, Toxicology & Technology, Inc. (ST&T Research). ST&T Research is comprised of a group of prominent scientist, including M.D. and Ph.D. pharmacologists/toxicologist and research product development oriented physicians, scientist, and regulatory compliance specialists which include a legal team specializing in USA FDA/FTC/Customs regulations. ST&T Research provides product development, product compliance, regulatory compliance, clinical testing, and information and data for safety and efficacy.

Dr. Robert A. Newman who serves as a scientific advisor to Nerium SkinCare assisted by providing safety data from previous studies, experience from a clinical trial at The University of Texas M. D. Anderson Cancer Center, and the analytical analysis for the determination of oleandrin (CG) in blood plasma. Nerium oleander is a known toxic plant that contains cardiac glycosides (CG) and therefore appropriate concerns for safety have to be demonstrated and confirmed for any new product.

ST&T Research initiated clinical human studies (4) for safety with topical application of a base cream which included the NAE-8® ingredient. The Nerium topical test article application was first applied as a spot treatment, then to increasingly larger areas of skin application with each new clinical study to evaluate absorption of the Nerium test article into the blood.  The studies included participants that exhibited various skin conditions to assist in the evaluation of the absorption of the Nerium topical test article with different skin conditions. A variety of compromised/damaged/broken skin conditions were presented as the application coverage area increased (age spots, actinic keratosis, acne vulgaris, sun burn, fever blisters and cold sores). Two (2) of these clinical studies included comparison to well-known OTC products currently available to consumers.

Each study's primary end-point was to evaluate the Nerium topical test articles for safety/toxicity on a variety of skin conditions, a) Determine if the Nerium oleander CG metabolites were being absorbed through the skin, b) If so, how much, c) If there was any noticeable blood pressure or heart rate changes, and d) If there were changes in blood chemistry or organ system functions. In addition, subjects were observed for inflammation, rash, or tenderness possibly related to the cream application.

ST&T utilized blood chemistry and CBC analysis whereby a comparison was made of the participant's baseline results with measurements taken throughout the study. As an example, participant blood samples were taken for baseline, on day one (1) (one hour after cream application), day seven (7), day fifteen (15), and on day thirty (30) of product use to test for oleandrin (CG) absorption and accumulation in the blood.

Analysis was non-eventful. The blood analysis showed all subjects within normal ranges, there were no detectable CG's in the blood and no adverse reactions noted. The cardiac glycosides contained in Nerium oleander extracts were NOT ABLE to penetrate the skin at detectable levels in the blood.

With regard to efficacy, ST&T was surprised to find there were a statistically significant number of subjects reporting positive benefit since the Nerium SkinCare test article contained no "additives" like the OTC products.

Continuing research and trials for Nerium SkinCare formulations are planned for all topical formulations for safety. Future studies are to include clinical evaluation for efficacy utilizing the latest testing technology available. Nerium SkinCare believes it will continue to demonstrate safety and new beneficial uses of its formulas.

Investigators: Science, Toxicology & Technology and its physicians / health care practitioners.
Sponsor: Nerium Biotechnology Inc. (NBI) / Nerium SkinCare, Inc.


New Product Development (NeriumAD®), Testing, and Launch

Nerium Skincare has formulated/developed its initial new product for market launch, NeriumAD® Age–Defying Night Cream. Exclusive distribution of NeriumAD® is provided for in a licensing agreement with Nerium International, LLC.

Anti-aging skin creams are abundant in today's cosmetic marketplace. New ingredients that may provide additional efficacy are sought to improve existing products. The NeriumAD® formulation is specifically designed for this market and provides two (2) such ingredients, NAE-8®  and a proprietary peptide matrix.

Clinical testing was provided by ST&T Research utilizing technology from the semi-conductor industry, now transferred to the skin care industry. Test subject outcomes included subjective and objective evaluation of changes in appearance of fine lines and wrinkles, discoloration, and uneven skin texture, using an advanced R&D model fluorescence spectroscopy skin analyzer.

Investigators: Science, Toxicology & Technology and its physicians / health care practitioners.
Sponsor: Nerium SkinCare, Inc.